BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20209693)

  • 1. Correlation of eosinophil derived neurotoxin with airway resistance in asthmatics.
    Badar A; Hussain MM; Saeed W; Aslam M
    J Pak Med Assoc; 2010 Feb; 60(2):97-101. PubMed ID: 20209693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.
    Gon Y; Ito R; Hattori T; Hiranuma H; Kumasawa F; Kozu Y; Endo D; Koyama D; Shintani Y; Eriko T; Soda K; Maruoka S; Hashimoto S
    Allergy Asthma Proc; 2015; 36(6):e113-20. PubMed ID: 26534742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
    Kim CK; Callaway Z; Fletcher R; Koh YY
    J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
    Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
    Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma.
    Kim CK; Callaway Z; Park JS; Kwon E
    Allergol Int; 2017 Jan; 66(1):70-74. PubMed ID: 27329145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.
    Kim KW; Lee KE; Kim ES; Song TW; Sohn MH; Kim KE
    Lung; 2007; 185(2):97-103. PubMed ID: 17393238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
    Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of eosinophil cationic protein with severity of asthma.
    Badar A; Saeed W; Hussain MM; Aslam M
    J Ayub Med Coll Abbottabad; 2004; 16(3):66-71. PubMed ID: 15631377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts.
    An J; Lee JH; Sim JH; Song WJ; Kwon HS; Cho YS; Moon HB; Kim CK; Kim TB
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2681-2688.e1. PubMed ID: 32304842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
    Cottin V; Deviller P; Tardy F; Cordier JF
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough.
    Kim CK; Callaway Z; Kim DW; Kita H
    J Asthma; 2011 Dec; 48(10):994-1000. PubMed ID: 22022864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.
    Sedgwick JB; Vrtis RF; Jansen KJ; Kita H; Bartemes K; Busse WW
    J Allergy Clin Immunol; 2004 Sep; 114(3):568-74. PubMed ID: 15356558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Airway inflammation and peripheral airway function in asthmatic patients with different control levels].
    Pan Y; Huang KW; Ye Q; Liu XS; Wu BM; Zhang J; Chang XH; Lu Y; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):679-84. PubMed ID: 20079282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
    Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
    J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in eosinophil biomarkers by benralizumab in patients with asthma.
    Pham TH; Damera G; Newbold P; Ranade K
    Respir Med; 2016 Feb; 111():21-9. PubMed ID: 26775606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eosinophil count in asthma. A marker of disease activity in intrinsic and extrinsic asthma].
    Ulrik CS
    Ugeskr Laeger; 1996 Jun; 158(25):3612-6. PubMed ID: 8693621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary eosinophil-derived neurotoxin is associated with reduced lung function in pediatric asthma.
    Omony J; Thölken C; Salimi A; Laubhahn K; Illi S; Weckmann M; Grychtol R; Rabe KF; Thiele D; Foth S; Weber S; Brinkmann F; Kopp MV; Hansen G; Renz H; von Mutius E; Schaub B; Skevaki C;
    Pediatr Allergy Immunol; 2024 Jun; 35(6):e14172. PubMed ID: 38873905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
    Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
    Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of EDN levels in patients with asthma and correlation with FEV
    Kuai S; Zhao P
    Allergy Asthma Proc; 2023 Jul; 44(4):244-251. PubMed ID: 37480200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.